{"name":"Biohaven Pharmaceuticals, Inc.","slug":"biohaven-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BHV-0223","genericName":"BHV-0223","slug":"bhv-0223","indication":"Other","status":"phase_2"},{"name":"BHV3241, verdiperstat","genericName":"BHV3241, verdiperstat","slug":"bhv3241-verdiperstat","indication":"Multiple system atrophy (MSA)","status":"phase_2"}]}],"pipeline":[{"name":"BHV-0223","genericName":"BHV-0223","slug":"bhv-0223","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BHV3241, verdiperstat","genericName":"BHV3241, verdiperstat","slug":"bhv3241-verdiperstat","phase":"phase_2","mechanism":"BHV3241, also known as verdiperstat, is a small molecule inhibitor of the enzyme NADPH oxidase 2 (NOX2).","indications":["Multiple system atrophy (MSA)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxOOGhDYjBKcUZXZGY0SmRFLWlXYWdxWDJFa1NFY2hGZE5IcUxTSlNYZkJUenNNTGpjSnhqMHM1RmJmaTVNZVN5WjRzY2N6a1ZqRnZzN3F0QTBUdzdQMzVxVkNsSEg2V3pQYWJBTHBsTzVxdHNaaHpoaXdrVUw0Tm00SEtHeks3YXVDSUF1blZSV2t5bVBXTlYtelFyclIxcGU2WUFzTTFNN09kd1JKbkhYaVVUSVZuT292TnEtbTJ5Tm9Ta0NONDFoYkxLUlF0UUNDUEs1V25xVHFyRzVjSVhaMVJFeTMteEFBNGFPVnNBYUswNHYzc0tEVzV4akNsakZIRGVrTUx2Z0d0WGNLY1g3SW41SVc2ckg3djVTVmNRQUxZQ0NpSi14RTN1cDk2ZnRZY1FlZjBRSnh1ZUpOS0ptMF9VY2Z2VlcwYm84WmhpOA?oc=5","date":"2026-04-03","type":"pipeline","source":"Barchart","summary":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro -","headline":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPMXUwMXozVXRFT3o2MGIwMTYwN01LZkJKMGpvS2lzZ01sa2FPQUljQU5mLXBnM1VkbTJiUFB3SGxYT1p4QTFYczA4UElqdGo5NGRnVGItX1BXZ1YtRDFGVTRlbS11aUlOY1ZFdHBwR1lzeU9TZHhPT1RLWU9NSXFFRWlDU0ZSVWVadE82UGhfcjBHMkM4aE5XcWxScm1xaVJudXdsYTkyZ29Ra3haay1nWk1jaDROYzZDSEdILTVhS0JsUQ?oc=5","date":"2025-01-29","type":"pipeline","source":"Hartford Business Journal","summary":"Pfizer to pay nearly $60M over kickbacks for migraine drug developed by New Haven-based Biohaven - Hartford Business Journal","headline":"Pfizer to pay nearly $60M over kickbacks for migraine drug developed by New Haven-based Biohaven","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQcG5YVHdPRkFjUlp4MHk1RXZGSnZVZWgtclBvdEdXWjJZXzFHUE1MT3dLX0JuMXBrSmc0Z3NvNmhvaFEzcmNFeVhCZWNpYUYwUTgwa3M2LVJZMGgzYXpFZ0F2dHdLYU1jRFV1bHZWZE85UTdHT1FDcFZOcnRlb1dTeG1yd2dxd0k0My1EY1VMbU5MYnZ6djVYaGJEMFdXTWN6djZMQQ?oc=5","date":"2025-01-27","type":"pipeline","source":"Pharmaceutical Technology","summary":"Pfizer settles Biohaven kickback claims case for $59.7m - Pharmaceutical Technology","headline":"Pfizer settles Biohaven kickback claims case for $59.7m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPdDNVSjYwYk1PS01GbDY0UUZTeGNBMF96U1A2TnJlcDlEZkJCSl9pVUdhbTBTTXZDMUtCM0s4dkp2bGt4TE8yRVltZ0lZdDV4NXU4allTS3g3Qk9NN2R0R01ybUlWNHF1YnZfTThPTE9WYXR5VkNURnluZ1NrdFRkZ05VSGpBVnFwdnZiUmhxV2RMMWh5dXViY3JMNnBpUVZRN0xuWTg4TGJuQXNuaEZwbXFzNnY1RVlueW04cmNWQlRBdw?oc=5","date":"2024-09-23","type":"trial","source":"Reuters","summary":"Biohaven surges as genetic disease drug meets main study goal - Reuters","headline":"Biohaven surges as genetic disease drug meets main study goal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQU1ctMHBYSkRGd1hreGJJdEYxVXNGMkIwSjMxTWYxY2Z4clBqTXkyQklLWWU1bTRYdTJ3XzZSeXdJME1oRXF0Z3k5dnBnLTd4UnowOTgtanpfbnJKVFR2bk56amtSdEw4Y1l3TmxTR0RPTTN0aWdLaW50Sm1ON1hON2NSNl8wcTdRUVhWUnVPOTJ1eThEc0VB?oc=5","date":"2024-08-08","type":"pipeline","source":"Yahoo Finance","summary":"Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In? - Yahoo Finance","headline":"Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Inve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOZjZ0NHl3LXhLN2t3cXZoS2Z2bS1rNXo3Wm1NYUpiSEVNcjRxVEMxck1yMy1SM3lEZk1ucHhiY3lYYUI0TUUzSkV6M0xxUy1yTHc0dEtya293Q3FTLUZVZTQyMnN0eTZSUy1Mb0tqcVk3aFJha3QtVk9aUzBXU200dTBXRElscW9hTjVSQnM1MV9yYjZrRFVqa1VtbFlHSDFYSFhqZUh6RTEydmQyZ1UzWHk4RUNRbWFFTHRLWlFURHZpRHk3OHE0?oc=5","date":"2022-10-24","type":"trial","source":"Fierce Pharma","summary":"Biohaven takes the unusual step of plugging not a drug but an experimental trial with a flashy marketing video - Fierce Pharma","headline":"Biohaven takes the unusual step of plugging not a drug but an experimental trial with a flashy marketing video","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPblN1Rjcta0dYbUJyZkd2anJLVDkweHBRUVpGLXFCYU9uc2pDaDNxVEhPNThxOW9zZXpqYVZWNWtzMlpXaUlfbUQ5Vi1WOUpnSExrTDl4bWlqSzIzRkJTUjlLdDczYkR1MGJqeWRmWC0tUGU5bU9oVUplNThxNWx2a0J1Ny1xaWRDak5JS3RnNTB2NlVBMERrN1JyYVI?oc=5","date":"2022-10-05","type":"deal","source":"BioPharma Dive","summary":"Biohaven starts life as new company following Pfizer buyout - BioPharma Dive","headline":"Biohaven starts life as new company following Pfizer buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPOXpNeThPazZqeFM2YXAxMGc0Ukc2X3VQcVlQYTNYYWFjTXRpcm50UGFjclJVM3lzWUlGNVUtYVRKcHdvN19hZDVYRHNkZl9OSFg1OTF3SkRZTW5waTlpcUxWWEF1UGNDNjczcTBMbVJuTTVFRGtBdDBudW12T01zd2R5REc2U2hhUlExQ2kxWkNXVk12N3pBV1M5VWdlY3A5RHBNTnlpT3A?oc=5","date":"2022-05-10","type":"deal","source":"MedCity News","summary":"Pfizer buys its way into migraine with $11.6B Biohaven Pharma acquisition - MedCity News","headline":"Pfizer buys its way into migraine with $11.6B Biohaven Pharma acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPandST0Y2SXlJQnptLUdtUXZ0SGxPaEdCM3NTR2dkMmhpUUVxZ1gzZ2J1OHdBOHNua1lLNE5RVnd6QUZXSjI4Y3B4RXU2S0tsS0ZsWEt5M3RaLWVGbHNTRnRxY2F0M0JkSXBwSTBZanBCSU1yTHFhWHNZbmQ0bnVsQUhOTWpwd25JNzMteHBldmxQRGxQdDhyZWgyWEN0b1JSXzQ2RTkwcThscEM1akwxcmhPbGdDWGMwNHF6X3RVLW8?oc=5","date":"2022-05-10","type":"deal","source":"Bloomberg.com","summary":"Pfizer’s Biohaven Deal May Open an Era of Smarter Pharma Acquisitions - Bloomberg.com","headline":"Pfizer’s Biohaven Deal May Open an Era of Smarter Pharma Acquisitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPOUZjTTMwX2dtTjFkdkZycDhrdnJSal9nRjhkcVptRlBXa3NwZTVHNXBnZmIzdEx1aXlCVWFlMC1oeEZjUE5POVdNaXlkeXFlUmM2aEQxdVRPZFh3V3l3Rk91TnFJX0VnbWowYjJhM29WbjJaVVM5cU5HU0dPVXhCaDZxWGRJMnE4dEVGUko1YWhwaG9vdC1ES3Zpc0RKMmpxS3A4ZTBR?oc=5","date":"2021-01-08","type":"regulatory","source":"Contract Pharma","summary":"Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals - Contract Pharma","headline":"Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQSERQelNaLXZnOHFURWlibzVtdmdXTnhNd3JFaGx5WjhzRXhIOC1lT0Y4YmJBd0pNTm8yRTNVOTY2aC13UW1DM2gzbnRrRGVPdkR3OUxlby1UWjlBeHhNRWM5Ul90YXlkNHZUbGpaVUU4M1R0d0xfV2pXZGNxVWtpVzNNTmtsVXdSUExObjBZakU5SkM2azBlcnVYS1pVXzltbkowZzR5eFUtaF85aXRKcnBISmVRNURjOG1TekluTFA5eF96a2pHZGF4SHZwWmp4Zkg3emJIM0FQUDY1TlZsVDRlcHJqTnV4M3NzaTRRRjJXNmU1YU0weUZIWmFXUE0?oc=5","date":"2021-01-07","type":"deal","source":"PR Newswire","summary":"Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs - PR Newswire","headline":"Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxObGVPaEFBVHc5aVFyWVZkTGNIWF9WQUV4RDl3U3E1dFVvY29BMDNndkhBY09xMFg4ZUkxdi1yN0NpUUtkM3dZQk82aHR6SW1SaTRhTjViNm1uT0VURnRwal9oWHVXdjREdFVwbldOT1p2eVA2d3FwdHpHQkxNTDRKaWlBSzc4Tm9lR2UyLUs3Z1M0ZlNpWWNseURnUFNaMEU0WTBGeHpvSFlRdlEyVFhjMlhpeG1tSl9nQ1lKWDZqakdnOVpJcGxqUDFBcmZNbld5UXlaZ3poUXQ1cUlaRXBF?oc=5","date":"2020-04-16","type":"deal","source":"PR Newswire","summary":"Biohaven Enters Into Partnership With Medison Pharma To Distribute NURTEC™ ODT In Israel - PR Newswire","headline":"Biohaven Enters Into Partnership With Medison Pharma To Distribute NURTEC™ ODT In Israel","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}